KraneShares MSCI All China Health Care Index ETF Price & Performance (KURE)

U.S. investors could be forced to divest as much as $800 billion from Chinese stocks if relations deteriorate further, with major funds like the Kraneshares CSI China Internet Fund at risk. Analysts warn that delistings could trigger rapid selloffs and significant price declines for American depositary receipts.12

The KraneShares MSCI All China Health Care Index ETF (KURE) has outperformed many global pharma ETFs, gaining 2.88% year-to-date despite sector-wide declines driven by new U.S. tariffs. The fund’s focus on Chinese healthcare appears to buffer it from some of the volatility impacting U.S.-listed pharmaceutical peers.34

After a brief drop in early April, the KraneShares MSCI All China Health Care Index ETF rebounded sharply, posting a 10% gain over five days. This performance underscores investor appetite for Chinese healthcare stocks as a safe haven amid ongoing U.S.-China trade uncertainty and global market turbulence.56